Stocks
Allogene Therapeutics (ALLO) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -184.8 | -220.5 | -237.7 | -200.3 | -149.2 | -109.2 | ||
| Changes by years, y/y, % | +61% | +19% | +8% | -16% | -25% | +5.3% | |||
Allogene Therapeutics. OCF, bln rub
Allogene Therapeutics. OCF, changes, %
Allogene Therapeutics. OCF, sum by quarters, bln rub
Allogene Therapeutics (ALLO) OCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OCF, bln rub | ? | -52.9 | -39.0 | -29.7 | -27.6 | -12.9 | -109.2 | |
| Changes by years, y/y, % | -5% | -39% | -33% | -25% | -76% | |||
| Changes by quarters, q/q, % | +44% | -26% | -24% | -7% | -53% | |||
